If a patient experiences liver failure impairing detoxification processes, which consequence follows regarding drug metabolism?

💡 Explanation

Increased bioavailability occurs because liver failure reduces the first-pass metabolism, the process by which the liver breaks down drugs before they reach systemic circulation; therefore, a greater proportion of the drug enters the bloodstream, rather than being metabolized by the liver.

• Which outcome is most likely in an individual with hypertension whose kidneys exhibit increased aldosterone production but normal angiotensin II levels?
• Why does adaptation to high concentrations of saccharin result in a reduced perceived sweetness of other sweeteners with different chemical structures?
• Which mechanism causes reduced salt perception after paralysis of facial nerves?
• What causes reduced sensation of fullness after eating in obese individuals with leptin resistance?
• If a patient with retinitis pigmentosa experiences increasing peripheral vision loss, what explains why gene therapy targeting photoreceptor survival might fail to fully restore vision?
• If a patient maintains chronically low vitamin D levels while consuming adequate calcium and phosphorus, which consequence becomes most likely regarding bone mineral density?